BML Capital Management’s ImageneBio Inc IMA Stock Holding History

BML Capital Management’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$919K	Hold	200,730	–	–	0.49%	17
2026 Q2	$1.18M	Hold	200,730	–	–	0.67%	15
2026 Q1	$1M	Buy	200,730 +23,704	+13%	+$154K	0.64%	15
2025 Q4	$1.22M	Sell	177,026 -5,483	-3%	-$40.7K	1.06%	12
2025 Q3	$1.49M	Sell	182,509 -153,333	-46%	-$2.03M	1.36%	11
2025 Q2	$5.4M	Buy	335,842 +26,608	+9%	+$391K	4.09%	8
2025 Q1	$4.75M	Buy	309,234 +10,412	+3%	+$180K	3.84%	9
2024 Q4	$5.88M	Buy	298,822 +238,548	+396%	+$4.82M	3.65%	10
2024 Q3	$1.25M	Buy	60,274 +11,514	+24%	+$233K	0.74%	18
2024 Q2	$965K	Buy	+48,760	New	+$861K	0.69%	21

Other funds holding IMA

Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

BML Capital Management's IMA Position: Q3 2026 in Review

BML Capital Management held its ImageneBio Inc (IMA) position steady in Q3 2026 at 200,730 shares worth $919K. The position accounts for 0.49% of the portfolio, ranked #17.

BML Capital Management first reported a position in IMA in Q2 2024 and has held it in 10 quarters since. The position peaked at $5.88M in Q4 2024. 10 funds tracked by Wall St. Rank hold IMA as of Q3 2026.

BML Capital Management held 200,730 shares of ImageneBio Inc worth $919K as of Q3 2026.
BML Capital Management left its ImageneBio Inc share count unchanged in Q3 2026.
ImageneBio Inc made up 0.49% of BML Capital Management's portfolio in Q3 2026, its #17 holding.
BML Capital Management first reported a position in ImageneBio Inc in Q2 2024 and has held it in 10 quarters since.
BML Capital Management's ImageneBio Inc position peaked at $5.88M in Q4 2024.
10 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2026.

Based on BML Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.